GALNT3 and prostate carcinoma: Moreover, increased GALNT3 and GALNTT6 co-expression has been detected in pancreatic [26] and prostate carcinomas [27], and a strong correlation between both GALNT3 and GALNT6 expression has been reported during the different stages of endometriosis [28].